129 related articles for article (PubMed ID: 16971704)
21. Incretin mimetics as emerging treatments for type 2 diabetes.
Joy SV; Rodgers PT; Scates AC
Ann Pharmacother; 2005 Jan; 39(1):110-8. PubMed ID: 15562141
[TBL] [Abstract][Full Text] [Related]
22. [Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].
Kjeldsen R; Sandbaek A
Ugeskr Laeger; 2008 Sep; 170(39):3039-43. PubMed ID: 18822227
[TBL] [Abstract][Full Text] [Related]
23. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4).
Hiles RA; Bawdon RE; Petrella EM
Hum Exp Toxicol; 2003 Dec; 22(12):623-8. PubMed ID: 14992323
[TBL] [Abstract][Full Text] [Related]
25. New drugs: exenatide, pramlintide acetate, and micafungin sodium.
Hussar DA
J Am Pharm Assoc (2003); 2005; 45(4):524-7. PubMed ID: 16128511
[No Abstract] [Full Text] [Related]
26. [The role of incretins. Type 2 diabetes with new beginnings].
MMW Fortschr Med; 2005 Mar; 147(10):48-9. PubMed ID: 15803785
[No Abstract] [Full Text] [Related]
27. Pharmacologic management of the older patient with type 2 diabetes mellitus.
Neumiller JJ; Setter SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.
Nogid A; Pham DQ
Pharmacotherapy; 2006 Nov; 26(11):1626-40. PubMed ID: 17064208
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic role of incretin mimetics and DPP-4 inhibitors.
Funnell MM
Diabetes Educ; 2009; 35 Suppl 1():12S-7S. PubMed ID: 19218562
[TBL] [Abstract][Full Text] [Related]
30. First in class. Two new diabetes drugs.
Koredella T
Diabetes Forecast; 2005 Aug; 58(8):35-6. PubMed ID: 16124101
[No Abstract] [Full Text] [Related]
31. Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data.
Kruger DF; Gloster MA
Drugs; 2004; 64(13):1419-32. PubMed ID: 15212559
[TBL] [Abstract][Full Text] [Related]
32. Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus.
Paisley AN; Savage MW; Wiles PG
Diabet Med; 2009 Sep; 26(9):935-8. PubMed ID: 19719716
[TBL] [Abstract][Full Text] [Related]
33. Exenatide: a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea).
Cvetković RS; Plosker GL
Drugs; 2007; 67(6):935-54. PubMed ID: 17428109
[TBL] [Abstract][Full Text] [Related]
34. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
35. Diabetes: assessing the pipeline.
Lebovitz H
Atheroscler Suppl; 2006 Apr; 7(1):43-9. PubMed ID: 16504599
[TBL] [Abstract][Full Text] [Related]
36. Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data.
Gallwitz B
Int J Clin Pract; 2006 Dec; 60(12):1654-61. PubMed ID: 17109672
[TBL] [Abstract][Full Text] [Related]
37. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929
[TBL] [Abstract][Full Text] [Related]
38. Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus.
Lam S; See S
Cardiol Rev; 2006; 14(4):205-11. PubMed ID: 16788334
[TBL] [Abstract][Full Text] [Related]
39. [Clinical application of exenatide in Japanese patients with type 2 diabetes mellitus].
Toyonaga T; Araki E
Nihon Rinsho; 2011 May; 69(5):890-4. PubMed ID: 21595277
[TBL] [Abstract][Full Text] [Related]
40. Focus on incretin-based therapies: targeting the core defects of type 2 diabetes.
Jellinger PS
Postgrad Med; 2011 Jan; 123(1):53-65. PubMed ID: 21293084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
